Learn More
Description
The 429 monoclonal antibody specifically binds to both the long (ñ110 kDa) transmembrane-spanning form and the truncated (ñ47 kDa) GPI-linked form of vascular cell adhesion molecule-1 (VCAM-1, CD106). CD106 is constitutively expressed on bone marrow stromal cells, myeloid cells, and splenic dendritic cells. Its expression on endothelial cells is upregulated by inflammatory cytokines and in certain pathologic conditions. CD106 expression has also been detected on apoptotic thymocytes, splenocytes, and lymphoid cell lines. VCAM-1 is a counter-receptor for VLA-4 (α4β1 integrin) and LPAM-1 (α4β7 integrin), and the 429 antibody partially blocks VCAM-1-mediated binding functions. Source of the immunogen was the mouse preadipose cell line PA6.
Specifications
Specifications
| Antigen | CD106 |
| Classification | Monoclonal |
| Clone | 429 (MVCAM.A) |
| Concentration | 0.2mg/mL |
| Conjugate | Brilliant Blue 700 (BB700) |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Gene Alias | Vcam-1, Vascular cell adhesion molecule 1, Vascular cell adhesion protein 1 |
| Host Species | Rat |
| Immunogen | Mouse preadipose cell line PA6 |
| Purification Method | Affinity Purified |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.